Turtlemint Fintech IPO 首日：散户投资者引领谨慎开局

Turtlemint Fintech Solutions IPO 在认购首日反应平淡，散户投资者的热情高于机构投资者。由于认购期将持续至 6 月 23 日，市场参与者正密切关注灰市溢价 (GMP) 和券商情绪，以评估此次发行的最终成功程度。

认购情况：散户投资者带动早期势头

在认购首日，截至上午 11 点，总认购率仅为 2%。虽然整体市场反应显得较为谨慎，但个人散户投资者 (RIIs) 板块提供了最初的动力，已认购其分配份额的 10%（604.6 万股）。

相比之下，机构板块的起步较为缓慢。截至目前的初步报告期，合格机构投资者 (QIBs)（预留 1770 万股）和非机构投资者 (NIIs)（提供 907.2 万股）均未记录到认购。此次发行总规模约为 88.3 亿卢比，其中包括 66.07 亿卢比的新股发行和 22.19 亿卢比的老股转让 (OFS)。

灰市趋势与定价预期

Turtlemint 的灰市溢价 (GMP) 目前在 2% 左右波动，表明市场预期上市表现将相对平淡或低迷。根据目前的灰市信号，考虑到每股 144-152 卢比的价格区间上限，预计上市价格约为 154 卢比。对于寻求快速上市收益的投资者而言，这些指标表明即时上涨空间有限。

业务模式与财务状况

Turtlemint 运营着一个技术驱动型保险分销平台，利用其拥有超过 50.7 万名认证销售点人员 (PoSPs) 和 63.2 万名数字合作伙伴的海量网络。虽然公司已将业务扩展至共同基金和贷款分销领域，但其核心优势仍在于人寿、健康和车险。

From a financial perspective, the company's trajectory is a mix of high growth and persistent losses. Turtlemint reported a revenue of Rs 662.7 crore in FY25, marking a sharp recovery from the previous year. However, the company remains in the red, reporting a net loss of Rs 194 crore during the same period. The fresh capital raised is earmarked for technology development, cloud infrastructure, marketing, and potential inorganic growth opportunities.

Divergent Brokerage Views

Market experts are divided on whether to participate in this offering:

  • SMIFS (Subscribe): The brokerage maintains a positive outlook, highlighting Turtlemint's leadership in the PoSP segment and its ability to capitalize on India's rising insurance penetration through AI-led automation and cross-selling.
  • Swastika Investmart (Avoid): Taking a more conservative stance, this brokerage suggests avoiding the IPO if the goal is short-term listing gains. They view the issue as a high-risk, long-term play suited only for those betting on eventual market leadership.

Key Takeaways

  • Cautious Start: Retail investors led Day 1 with a 10% subscription, while QIB and NII segments remained un subscribed in the early hours.
  • Muted GMP: A low Grey Market Premium of around 2% indicates that the stock may see a limited listing gain.
  • Growth vs. Profitability: While revenue has seen a significant recovery to Rs 662.7 crore, the company is still navigating a path to profitability after posting a Rs 194 crore loss in FY25.